DarioHealth Corp. (DRIO) Receives Daily News Sentiment Rating of 0.10

Media coverage about DarioHealth Corp. (NASDAQ:DRIO) has trended somewhat positive recently, according to Accern. The research group scores the sentiment of press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. DarioHealth Corp. earned a coverage optimism score of 0.10 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 48.1036358087746 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Receive News & Ratings for DarioHealth Corp. Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

DarioHealth Corp. (DRIO) opened at 2.0372 on Friday. The stock’s 50 day moving average is $2.41 and its 200 day moving average is $2.92. The stock’s market capitalization is $19.87 million. DarioHealth Corp. has a 12-month low of $1.81 and a 12-month high of $4.70.

DarioHealth Corp. (NASDAQ:DRIO) last released its quarterly earnings data on Monday, August 14th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.30) by $0.13. DarioHealth Corp. had a negative net margin of 206.95% and a negative return on equity of 626.32%. The company had revenue of $1.21 million for the quarter. Equities research analysts forecast that DarioHealth Corp. will post ($0.41) EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “[[title]]” was reported by [[site]] and is the sole property of of [[site]]. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this piece can be viewed at [[permalink]].

DarioHealth Corp. Company Profile

DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company’s product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter.